Antiviral Res. 2017 Jun 21;144:205-215. doi: 10.1016/j.antiviral.2017.06.016. [Epub ahead of print]
Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro.
Berke JM1, Tan Y2, Verbinnen T3, Dehertogh P3, Vergauwen K3, Vos A3, Lenz O3, Pauwels F3.